[PDF][PDF] Galleria mellonella–intracellular bacteria pathogen infection models: the ins and outs

M Asai, Y Li, SM Newton, BD Robertson… - FEMS Microbiology …, 2023 - academic.oup.com
Galleria mellonella (greater wax moth) larvae are used widely as surrogate infectious
disease models, due to ease of use and the presence of an innate immune system …

Recent advancements in the development of anti-tuberculosis drugs

S Chetty, M Ramesh, A Singh-Pillay… - Bioorganic & medicinal …, 2017 - Elsevier
Modern chemotherapy has significantly improved patient outcomes against drug-sensitive
tuberculosis. However, the rapid emergence of drug-resistant tuberculosis, together with the …

Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance

ES Kavvas, E Catoiu, N Mih, JT Yurkovich… - Nature …, 2018 - nature.com
Mycobacterium tuberculosis is a serious human pathogen threat exhibiting complex
evolution of antimicrobial resistance (AMR). Accordingly, the many publicly available …

Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide

P Santucci, DJ Greenwood, A Fearns, K Chen… - Nature …, 2021 - nature.com
To be effective, chemotherapy against tuberculosis (TB) must kill the intracellular population
of the pathogen, Mycobacterium tuberculosis. However, how host cell microenvironments …

Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance

H Safi, P Gopal, S Lingaraju, S Ma… - Proceedings of the …, 2019 - National Acad Sciences
The length and complexity of tuberculosis (TB) therapy, as well as the propensity of
Mycobacterium tuberculosis to develop drug resistance, are major barriers to global TB …

Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy

MM Bellerose, SH Baek, CC Huang, CE Moss, EI Koh… - MBio, 2019 - Am Soc Microbiol
Despite the administration of multiple drugs that are highly effective in vitro, tuberculosis (TB)
treatment requires prolonged drug administration and is confounded by the emergence of …

Pyrazinamide triggers degradation of its target aspartate decarboxylase

P Gopal, JP Sarathy, M Yee, P Ragunathan… - Nature …, 2020 - nature.com
Pyrazinamide is a sterilizing first-line tuberculosis drug. Genetic, metabolomic and
biophysical analyses previously demonstrated that pyrazinoic acid, the bioactive form of the …

A biochemically-interpretable machine learning classifier for microbial GWAS

ES Kavvas, L Yang, JM Monk, D Heckmann… - Nature …, 2020 - nature.com
Current machine learning classifiers have successfully been applied to whole-genome
sequencing data to identify genetic determinants of antimicrobial resistance (AMR), but they …

Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

T Lane, DP Russo, KM Zorn, AM Clark… - Molecular …, 2018 - ACS Publications
Tuberculosis is a global health dilemma. In 2016, the WHO reported 10.4 million incidences
and 1.7 million deaths. The need to develop new treatments for those infected with …

Acid fasting: modulation of Mycobacterium tuberculosis metabolism at acidic pH

JJ Baker, SJ Dechow, RB Abramovitch - Trends in microbiology, 2019 - cell.com
Mycobacterium tuberculosis (Mtb) senses and adapts to acidic host environments during the
course of pathogenesis. Mutants defective in acidic pH-dependent adaptations are often …